June 24th, 2019 by aveciapharma
Nitto Avecia Pharma Services, Inc. has a focused vision. We envision each engagement with prospective or long-term clients as an opportunity to deliver innovative ideas that support their mission. Our corporate vision is "Creating Wonders," and we take that to heart with each service we provide, priding...
Posted in: Outsourced Pharma
January 30th, 2019 by aveciapharma
Click here to download Nitto Avecia Pharma Services Corporate Overview brochure....
Posted in: Outsourced Pharma
February 1st, 2018 by aveciapharma
CAMBRIDGE, MA – Nitto Denko Avecia, Inc. (Avecia), a leader in oligonucleotide API (active pharmaceutical ingredient) manufacturing, announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible...
Posted in: Company News, Press Release
January 15th, 2018 by aveciapharma
NITTO AVECIA PHARMA SERVICES APPOINTS RAYMOND KACZMAREK AS PRESIDENT IRVINE, CA – Nitto Avecia Pharma Services, Inc. (Avecia Pharma), a leading CGMP contract development and manufacturing organization (CDMO), announced today that it has appointed Raymond Kaczmarek to the position of President....
Posted in: Company News, Press Release
November 7th, 2017 by aveciapharma
MILFORD, MA – Nitto Avecia, Inc. (Avecia) announced today the successful completion of the first synthesis runs at the 1.6 Mol scale which is believed to be the largest synthesis scale ever executed for oligonucleotide API (active pharmaceutical ingredients) at its new oligonucleotide manufacturing facility...
Posted in: Press Release
July 26th, 2017 by aveciapharma
Nitto Denko Avecia Inc. (Avecia) has announced the opening of its new oligonucleotide API (active pharmaceutical ingredients) manufacturing facility in Milford, MA. The opening will commence with a ribbon cutting ceremony in August 2017 onsite at the Milford, MA facility. The ceremony will open with...
Posted in: Company News
May 17th, 2017 by aveciapharma
It's been a busy month so far at Nitto Avecia Pharma Services! We exhibited at two major industry events, both held in San Diego - the 2017 AAPS National Biotechnology Conference and the 2017 TIDES Oligonucleotide and Peptide Therapeutics Annual Meeting. These events gave us the opportunity to meet with...
Posted in: Company News
April 25th, 2017 by aveciapharma
We will be attending the AAPS National Biotechnology Conference in San Diego from May 1st to May 3rd. This year's main topics for the conference will be: Bioanalysis & Biomarkers, Biosimilars, Emerging Topics, Formulation Development, Drug Delivery & Manufacturing, and Novel Therapeutic Constructs &...
Posted in: Company News
November 14th, 2016 by aveciapharma
MILFORD, MA – Nitto Avecia Inc. (Avecia) today released its progress in expanding the company’s analytical development and oligonucleotide manufacturing capacities. The announcement signals the continuation of Avecia’s robust growth strategy to significantly increase its oligonucleotide...
Posted in: Press Release
October 11th, 2016 by aveciapharma
MILFORD, MA – Nitto Denko Avecia, Inc. (Avecia), today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio Biopharmaceuticals (Avrio), both located in Irvine, CA. Irvine is a leading analytical development services...
Posted in: Company News, Press Release